Can VR games restore lost vision in young brain tumor survivors?

NCT ID NCT07558395

Not yet recruiting Symptom relief Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a virtual reality program can improve vision in 120 children, teens, and young adults who have lost part of their visual field (hemianopsia) after a brain tumor. Participants will use a VR headset at home for 8 weeks to do visual exercises. The goal is to see if this can help them see more in their blind area and improve their daily life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: virtual reality visual stimulation program (3D-MOT)
What this could lead to: If it works, this could offer a home-based way to improve visual field loss and quality of life for young brain tumor survivors.
What could go wrong: This is an early-stage trial with no prior results, so the program may not improve vision. The effect may also vary from person to person.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMIANOPSIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain cancer Hemianopsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMIANOPSIA PEDIATRIC BRAIN TUMOR VIRTUAL REALITY VISUAL REHABILITATION

Contacts and locations

Locations

Department of Paediatric and adolescents medicine, Medical University

Vienna, Austria
Great Ormond Street Hospital for Children

London, United Kingdom
Hôpital de Hautepierre

Strasbourg, France
Institute of Tumour, department of haematology and Oncohaematology paediatric

Milan, Italy
Paediatric Haematology, University Hospital

Padova, Italy
Paediatric Oncology, San Joan de Deu

Barcelona, Spain
Paediatrics and Adolescents Medicine, University Hospital

Copenhagen, Denmark
Princess Maxima Centre for Paediatric Oncology

Utrecht, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.